Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamuel Heath Regulatory News (HSM)

Share Price Information for Samuel Heath (HSM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 275.00
Bid: 250.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 50.00 (20.00%)
Open: 275.00
High: 275.00
Low: 275.00
Prev. Close: 275.00
HSM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

9 Jul 2009 07:00

RNS Number : 3622V
Heath(Samuel) & Sons PLC
09 July 2009
 



HEATH (Samuel) & SONS PLC

9th JULY 2009

PRELIMINARY RESULTS FOR THE YEAR ENDED 31ST MARCH 2009

CHAIRMAN'S STATEMENT

As I warned at the half-year stage, trading collapsed at the end of September 2008. The result is that we are showing a profit before taxation for the year to 31st March 2009 of £292,000 against £1,392,000 the previous year, on sales down from £12,085,000 to £10,897,000.

Difficulties for businesses like ours have been well chronicled elsewhere and ours was certainly no exception. With a drop in sales as sudden and severe as this, it is very difficult to repair the damage immediately. Overall, but mainly on the manufacturing side of the business, we made 16% of our people redundant. A figure of £162,000 of redundancy payments is included in our profit figure.

Our profit before taxation for the first time has been enhanced by the capitalisation of Research and Development expenditure of £164,000. This now needs to be declared under International Financial Reporting Standards (IFRS), but I perhaps should point out, that the effect of this change is tax neutral.

Significant numbers of our customers have gone out of business, with regrettably no sign that this process has ended. Added to our problems was the reluctance of our credit insurers to continue cover on many of our clients, both home and overseas. This has had the bizarre effect of limiting already much curtailed sales. With these factors in mind, we have taken a cautious view of our bad debts and stock valuation.

Your Directors believe that a purchase of the Company's shares at the right price level could benefit the Company, and thereby its shareholders. Accordingly, your Directors are seeking your approval for the purchase of up to 15% of the issued share capital, 380,148 shares, between Annual General Meetings.

What of the future? It is quite clear that things are not going to return to normal in the short term. If we start to cut back on our sales and marketing side, we will do great harm to the business. We have therefore decided, for the time being, not to do so and to play the long game, which is perhaps not usual for a public company in the U.K. We understand however that in other countries, for a company of our size, this type of decision is normal. We are therefore budgeting for a manageable loss for the coming year, which only a much improved trading environment would eliminate.

The balance sheet remains strong with net assets at 31st March 2009 amounting to £6,709,000 (2008: £7,905,000). We have replaced some of our bank balances with other investments in order to protect the yield on these funds. However, in spite of the strength of this balance sheet, we feel it wise to halve the proposed final dividend to 6.25 pence per share.

Sam Heath

Chairman

9th July 2009

CONSOLIDATED INCOME STATEMENT

2009

2008

(Restated)

(Restated)

£000

£000

£000

£000

Continuing operations

Revenue

10,897 

12,085 

Cost of sales

(5,952)

(6,293)

Exceptional expenses (Redundancy payments)

(162)

(6,114)

(112)

(6,405)

--------

--------

--------

--------

Gross profit

4,783 

5,680 

Distribution costs

(3,036)

(3,003)

Administrative expenses

(1,504)

(1,495)

--------

--------

Operating profit

243 

1,182 

Finance income

593 

778 

Finance costs

(544)

(568)

--------

--------

Profit before taxation

292 

1,392 

Taxation 

23 

(345)

--------

--------

Profit for the year

315 

1,047 

====

====

Basic and diluted earnings per ordinary share

12.5p

41.3p

====

====

CONSOLIDATED BALANCE SHEET

2009

2008

£000

£000

Non current assets

Intangible assets

164 

Property, plant and equipment

2,617 

2,934 

Deferred tax asset

284 

101 

--------

--------

3,065 

3,035 

--------

--------

Current assets

Inventories

2,654 

2,787 

Trade and other receivables

1,753 

2,166 

Current tax receivable

88 

Available for sale financial assets

770 

Cash and cash equivalents

571 

1,728 

--------

--------

Total current assets

5,836 

6,681 

--------

--------

Total assets

8,901 

9,716 

====

====

Current liabilities

Trade and other payables

(859)

(986)

Derivative financial instruments

(103)

Current tax payable

(213)

--------

--------

Total current liabilities

(962)

(1,199)

--------

--------

Non current liabilities

Pension scheme deficit

(1,015)

(360)

Deferred tax liability

(215)

(252)

--------

--------

Total non current liabilities

(1,230)

(612)

--------

--------

Total liabilities

(2,192)

(1,811)

--------

--------

Net assets

6,709 

7,905 

--------

--------

Equity

Called up share capital

254 

254 

Capital redemption reserve

109 

109 

Retained earnings

6,346 

7,542 

--------

--------

Equity shareholders' funds

6,709 

7,905 

====

====

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Share

capital

Capital

redemption

reserve

Retained

earnings

Total

equity

£000

£000

£000

£000

Balance at 31 March 2007

254 

109 

7,251 

7,614 

Actuarial losses on defined benefit pension scheme

(200)

(200)

Deferred taxation on items taken to equity

40 

40 

--------

--------

--------

--------

Net income recognised directly in equity

(160)

(160)

Profit for the period

1,047

1,047

--------

--------

--------

--------

Total recognised income and expense for the period

887 

887 

Equity dividends paid

(596)

(596)

--------

--------

--------

--------

Balance at 31 March 2008

254 

109 

7,542 

7,905 

Actuarial loss on defined benefit pension scheme

(1,153)

(1,153)

Deferred taxation on items taken to equity

322 

322 

--------

--------

--------

--------

Net loss recognised directly in equity

(831)

(831)

Profit for the period

315 

315 

--------

--------

--------

--------

Total recognised income and expense for the period

(516)

(516)

Gains on available for sale financial assets

23 

23 

Cash flow hedges

(103)

(103)

Premium on purchase of own shares

(4)

(4)

Equity dividends paid

(596)

(596)

--------

--------

--------

--------

Balance at 31 March 2009

254 

109 

6,346 

6,709 

====

====

====

====

CONSOLIDATED AND PARENT CASH FLOW STATEMENTS 

Note

2009

2008

£000

£000

Net cash inflow from operating activities

6

458 

519 

--------

--------

Cash flow from investing activities

Purchases of property, plant and equipment

(203)

(226)

Proceeds from sale of property, plant and equipment

43 

33 

Purchase of intangible assets

(164)

- 

Purchase of available for sale financial assets

(747)

- 

Interest received

56 

97 

--------

--------

Net cash outflow from investing activities

(1,015)

(96)

--------

--------

Net cash outflow from financing activities

Purchase of own shares

(4)

- 

Equity dividends paid

(596)

(596)

--------

--------

Net cash outflow from financing activities

(600)

(596)

--------

--------

Decrease in cash and cash equivalents

(1,157)

(173)

Cash and cash equivalents at beginning of period

1,728 

1,901 

--------

--------

Cash and cash equivalents at end of period

571 

1,728 

====

====

1

Adoption of new and revised Standards

The Group has adopted all of the new and revised Standards and Interpretations issued by the International Accounting Standards Board (IASB) and the International Financial Reporting Interpretations Committee (IFRIC) of the IASB that are relevant to its operations and effective for accounting periods beginning on 1st April 2007. The adoption of the following IFRSs has not impacted upon the financial statements:

IFRIC 10 - Interim Financial Reporting and Impairment

At the date of authorisation of these financial statements, the following Standards and Interpretations which have not been applied in these financial statements were in issue but not yet effective:

IFRS 8 - Operating Segments

IFRIC 11 - Group and Treasury Share Transactions

These standards and interpretations are not expected to have any significant impact on the Group's financial statements, in their periods of initial application, except for the additional disclosures on operating segments when the relevant standard comes into effect for periods commencing on or after 1st January 2009.

2

Accounting policies

Basis of accounting

The financial statements, upon which this financial information is based, have been prepared using accounting policies consistent with International Financial Reporting Standards (IFRS).

The comparative figures in the Income Statement have been restated merely to reflect a more conventional presentation and have no affect on the overall profitability of the Group.

The financial statements have been prepared under the historical cost basis.

Intangible assets

Research and development costs represent typical internally generated assets of relevance for the Group. Costs incurred in relation to individual projects are capitalised only when the future economic benefit of the project is probable and it is the intention of management to complete the intangible asset and use it or sell it. 

Research costs are expensed as incurred.

For intangible assets with finite useful lives, amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over its useful economic life when the asset is available for use, as follows:

Research and development costs

20% per annum on cost

Hedging

The normal course of the Group's business exposes it to currency exchange rate fluctuations. In order to hedge this risk the Group has entered into foreign exchange contracts. This type of arrangement under IAS39 is classified as a "Cash Flow Hedge". The proportion of the gain or loss on the hedging instrument that is determined to be an effective hedge is recognised directly in equity, and the ineffective portion of the gain or loss on the hedging instrument is recognised in the income statement.

3

Critical accounting and key sources of estimation

Critical judgements in applying the entity's accounting policies

In the process of applying the entity's accounting policies, which are described above, the directors have made the following judgements that have the most significant effect on the amounts recognised in the financial statements.

Income taxes

The Group is subject to income taxes in the United Kingdom. Judgment is required in determining the provision for income taxes. There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Group recognises liabilities for anticipated tax audit issues based on estimates of whether additional taxes will be due. Where the final tax outcome of these matters is different from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.

The recoverable amounts of the Group's deferred tax assets have been determined based on the Board's estimates of future taxable profits and income and tax rates. 

Key sources of estimation uncertainty

The key assumptions concerning the future, and other key sources of estimation uncertainty at the balance sheet date, that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year, are discussed below.

Retirement benefit scheme deficit

The valuation of expected returns on assets and the present value of the liabilities of the scheme are determined by assumptions and estimates made by the directors based on the current information to hand. Therefore amounts are open to fluctuations in the future due to unforeseen changes or additional factors that come to light following the year end.

4

Dividends

2009

2008

£000

£000

Final dividend for the year ended 31st March 2008 of 12.5 pence per share (2007: 12.5 pence per share)

317 

317 

Interim dividend for the year ended 31st March 2009 of 11.0 pence per share (2008: 11.0 pence per share)

279 

279 

--------

--------

596 

596 

====

====

In addition to the dividends paid during the year the directors are recommending a final dividend for 2009 of 6.25 pence per share amounting to £158,000. The proposed final dividend is subject to approval at the Annual General Meeting (see note 7) and has not been included as a liability in these accounts.

5

Earnings per share

The basic and diluted earnings per share are calculated by dividing the relevant profit after taxation of £315,000 (2008: £1,047,000) by the average number of ordinary shares in issue during the year being 2,534,577 (2008: 2,535,000). The number of shares used in the calculation is the same for both basic and diluted earnings.

6

Notes to the cash flow statement

2009

2008

£000

£000

Results from operating activities

243 

1,182 

Depreciation of property, plant and equipment

471 

468 

Loss/(gain) on disposal of property, plant and equipment

12 

(8)

--------

--------

Operating cash flows before movements in working capital

726 

1,642 

Decrease/(increase) in inventories

133 

(142)

Decrease)/(increase) in receivables

413 

(31)

Decrease in payables

(133)

(197)

Pension contributions

(505)

(510)

--------

--------

Cash generated by operations

634 

762 

Income tax paid

(176)

(243)

--------

--------

Net cash flow from operating activities

458 

519 

====

====

Cash and cash equivalents (which are presented as a single class of assets on the face of the balance sheet) comprise cash at bank and other short-term highly liquid investments with a maturity of three months or less.

7

Annual General Meeting

The Annual General Meeting has been fixed for 14th August 2009 at 12 noon. The final Ordinary Share dividend of 6.25 pence, if approved, will be payable on 21st August 2009 to ordinary shareholders registered at close of business on 24th July 2009.

8

Section 240 statement (Section 435 of the Companies Act 2006)

The financial information set out above does not constitute the company's statutory accounts for the years ended 31st March 2009 or 2008. Statutory accounts for 2008 have been delivered to the Registrar of Companies, and those for 2009 will be delivered in due course. The auditors have reported on the 2008 accounts; their report was unqualified, did not include references to any matters by way of emphasis without qualifying their report and did not contain statements under Section 237 (2) or (3) of the Companies Act 1985 (Section 498 (2) or (3) of the Companies Act 2006).

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR SSAFIASUSEFW
Date   Source Headline
21st Nov 20237:00 amRNSHalf-year Report
7th Sep 20231:53 pmRNSResult of AGM
21st Jul 20237:00 amRNSFinal Results
9th Dec 20221:48 pmRNSHolding(s) in Company
9th Dec 20221:45 pmRNSDirector/PDMR Shareholding
18th Nov 20227:00 amRNSHalf-year Report
25th Aug 20223:08 pmRNSResult of AGM
20th Jul 202212:40 pmRNSReplacement: Final Results
20th Jul 20227:00 amRNSFinal Results
12th Nov 20217:00 amRNSHalf-year Report
6th Aug 20211:35 pmRNSResult of AGM
19th Jul 202110:14 amRNSDirectorate Change
8th Jul 20212:34 pmRNSFinal Results
30th Dec 20207:00 amRNSDirectorate Change
12th Nov 20207:00 amRNSHalf-year Report
7th Aug 20202:35 pmRNSResult of AGM
10th Jul 20207:30 amRNSFinal Results
9th Jul 20204:13 pmRNSHolding(s) in Company
8th Apr 20203:40 pmRNSCOVID-19 Trading Update
6th Feb 20207:00 amRNSDirectorate Change
18th Dec 20197:00 amRNSDirector/PDMR Shareholding
10th Dec 20199:53 amRNSDirectorate Change
15th Nov 20197:00 amRNSHalf-year Report
9th Aug 20192:45 pmRNSResult of AGM
15th Jul 20194:38 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSFinal Results
1st Apr 201911:47 amRNSPDMR/PCA Dealing
8th Nov 20187:00 amRNSHalf-year Report
10th Aug 20181:01 pmRNSResult of AGM
12th Jul 20183:26 pmRNSFinal Results
15th Jan 201811:13 amRNSDividend Record Date
9th Nov 20177:00 amRNSHalf-year Report
13th Oct 20179:45 amRNSHolding(s) in Company
13th Oct 20179:43 amRNSHolding(s) in Company
29th Sep 20177:00 amRNSDirectorate Change
1st Sep 20179:22 amRNSDirectorate Change
14th Aug 201711:48 amRNSResult of AGM
12th Jul 20179:33 amRNSFinal Results
16th Jun 20177:00 amRNSDirector/PDMR Shareholding - Replacement
10th May 20172:34 pmRNSDirector/PDMR Shareholding
7th Mar 20173:36 pmRNSDirector/PDMR Dealing
28th Feb 20177:00 amRNSDirectorate Change
16th Nov 20168:00 amRNSHalf-year Report
29th Sep 20163:59 pmRNSDirectorate Change
12th Aug 20161:26 pmRNSResult of AGM
11th Aug 201612:22 pmRNSDirectorate Change
13th Jul 20167:00 amRNSFinal Results
7th Jul 20162:32 pmRNSNotice of Results
6th May 20167:00 amRNSChange of Adviser
4th Nov 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.